Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer

Clinical Cancer Research

Volumn 8, Issue 4, 2002, Pages 1054-1060

  Ricciardelli, Carmela ^a   Brooks, John H ^a   Suwiwat, Supaporn ^a   Sakko, Andrew J ^a   Mayne, Keiko ^a   Raymond, Wendy A ^b   Seshadri, Ram ^b   LeBaron, Richard G ^c   Horsfall, David J ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOGLYCAN; VERSICAN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RECURRENCE; CANCER SURVIVAL; CELL CULTURE; CHEMOLUMINESCENCE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; CULTURE MEDIA, CONDITIONED; DISEASE-FREE SURVIVAL; FEMALE; FIBROBLASTS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; LYMPH NODES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROTEIN ISOFORMS; PROTEOCHONDROITIN SULFATES; STROMAL CELLS; TUMOR CELLS, CULTURED; VERSICANS;

EID: 0036554832     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Harris, J. R., Lippman, M. E., Veronesi, U., and Willet, W. Breast cancer. N. Engl. J. Med., 327: 473-480, 1992.
2. Mansour, E. G., Ravdin, P. M., and Dressler, L. Prognostic factors in early breast carcinoma. Cancer (Phila.), 74: 381-400, 1994.
3. Menard, S., Bufalino, R., Rilke, F., Cascinelli, N., Veronesi, U., and Colnaghi, M. I. Prognosis based on primary breast carcinoma instead of pathological nodal status. Br. J. Cancer, 70: 709-712, 1994.
4. Barth, A., Craig, P. H., and Silverstein, M. J. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer (Phila.), 79: 1918-1922, 1997.
5. Seshadri, R., Horsfall, D. J., McCaul, K., and Leong, A. S-Y. A simple index to predict prognosis independent of axillary node information in breast cancer. Aust. N. Z. J. Surgery, 67: 765-770, 1997.
6. Ricciardelli, C., Mayne, K., Sykes, P. J., Raymond, W. A., McCaul, K., Marshall, V. R., and Horsfall, D. J. Elevated levels of versican but not decorin predict disease progression in early stage prostate cancer. Clin. Cancer Res., 4: 963-971, 1998.
7. Ricciardelli, C., Quinn, D. I., Raymond, W. A., McCaul, K., Sutherland, P. D., Stricker, P. D., Grygiel, J. J., Sutherland, R. L., Marshall, V. R., Tilley, W. D., and Horsfall, D. J. Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early stage prostate cancer. Cancer Res., 59: 2324-2328, 1999.
8. Yamagata, M., Suzuki, S., Akiyama, S. K., Yamada, K. M., and Kimata, K. Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates. J. Biol. Chem., 264: 8012-8018, 1989.
9. Yamagata, M., Saga, S., Kato, M., Bernfield, M., and Kimata, K. Selective distributions of proteoglycans and ligands in pericellular matrix of cultured fibroblasts: implications for their roles in cell-substratum adhesion. J. Cell Sci., 106: 55-65, 1993.
10. Evanko, S. P., Angello, J. C., and Wight, T. N. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 19: 1004-1013, 1999.
11. Sakko, A. J., Ricciardelli, C., Mayne, K., Tilley, W. D., LeBaron, R. G., and Horsfall, D. J. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor β1. Cancer Res., 61: 926-930, 2001.
12. Seshadri, R., Leong, A. S-Y., McCaul, K., Firgaira, F. A., Setlur, V., and Horsfall, D. J. Relationship between p53 gene abnormalities and other tumour characteristics in breast cancer prognosis. Int. J. Cancer, 69: 135-141, 1996.
13. Elston, E. W., and Ellis, I. O. Method for grading breast cancer. J. Clin. Pathol., 46: 189-190, 1993.
14. du Cros, D. L., LeBaron, R. G., and Couchman, J. R. Association of versican with dermal matrices and its potential role in hair follicle development and cycling. J. Investig. Dermatol., 105: 426-431, 1995.
15. Nara, Y., Kato, Y., Torii, Y., Tsuji, Y., Nakagaki, S., Goto, S., Isobe, H., Nakashima, N., and Takeuchi, J. Immunohistochemical localization of extracellular matrix components in breast tumours with special reference to PG-M/versican. Histochem. J., 29: 21-30, 1997.
16. van Roozendaal, C. E., van Ooijen, B., Klijn, J. G. M., Claassen, C., Eggermont, A. M., Henzen-Logmans, S. C., and Foekens, J. A. Stromal influences on breast cancer cell growth. Br. J. Cancer, 65: 77-81, 1992.
17. Horsfall, D. J., Tilley, W. D., Orell, S. R., Marshall, V. R., and Cant, E. L. M. Relationship between ploidy and steroid hormone receptors in primary breast cancer. Br. J. Cancer, 53: 23-28, 1986.
18. Schmalfeldt, M., Dours-Zimmermann, M. T., Winterhalter, K. H., and Zimmermann, D. R. Versican V2 is a major extracellular matrix component of the mature bovine brain. J. Biol. Chem., 273: 15758-15764, 1998.
19. Lemire, J. M., Braun, K. R., Maurel, P., Kaplan, E. D., Schwartz, S.M., and Wight, T. N. Versican/PG-M isoforms in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 19: 1630-1639, 1999.